Cargando…
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities
Influenza is an acute respiratory infection causing high morbidity and mortality in annual outbreaks worldwide. Antiviral drugs are limited and pose the risk of resistance development, calling for new treatment options. IFN-α subtypes are immune-stimulatory cytokines with strong antiviral activities...
Autores principales: | Matos, Aline da Rocha, Wunderlich, Katharina, Schloer, Sebastian, Schughart, Klaus, Geffers, Robert, Seders, Martine, de Witt, Marlous, Christersson, Anmari, Wiewrodt, Rainer, Wiebe, Karsten, Barth, Peter, Hocke, Andreas, Hippenstiel, Stefan, Hönzke, Katja, Dittmer, Ulf, Sutter, Kathrin, Rescher, Ursula, Rodionycheva, Svetlana, Matera, Nicoletta, Ludwig, Stephan, Brunotte, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913622/ https://www.ncbi.nlm.nih.gov/pubmed/31826721 http://dx.doi.org/10.1080/22221751.2019.1698271 |
Ejemplares similares
-
3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases
por: Schloer, Sebastian, et al.
Publicado: (2022) -
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier
por: Faist, Aileen, et al.
Publicado: (2023) -
The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo
por: Schloer, Sebastian, et al.
Publicado: (2019) -
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
por: Brunotte, Linda, et al.
Publicado: (2021) -
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro
por: Schloer, Sebastian, et al.
Publicado: (2021)